The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
Open accessPublished version of a preprint
Abstract
BACKGROUND: The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths and disability-adjusted life-years (DALYs) averted by vaccination against ten pathogens in 98 LMICs between 2000 and 2030. METHODS: 16 independent research groups provided model-based disease burden estimates under a range of vaccination coverage scenarios for ten pathogens: hepatitis B virus, Haemophilus influenzae type B, human papillomavirus, Japanese encephalitis, measles, Neisseria meningitidis serogroup A, Streptococcus pneumoniae, rotavirus, rubella, and yellow fever. Using standardised demographic data and vaccine coverage, the impact of vaccination programmes was determined by comparing model estimates from a no-vaccination counterfactual scenario with those from a reported and projected vaccination scenario. We present deaths and DALYs averted between 2000 and 2030 by calendar year and by annual birth cohort. FINDINGS: We estimate that vaccination of the ten selected pathogens will have averted 69 million (95% credible interval 52-88) deaths between 2000 and 2030, of which 37 million (30-48) were averted between 2000 and 2019. From 2000 to 2019, this represents a 45% (36-58) reduction in deaths compared with the counterfactual scenario of no vaccination. Most of this impact is concentrated in a reduction in mortality among children younger than 5 years (57% reduction [52-66]), most notably from measles. Over the lifetime of birth cohorts born between 2000 and 2030, we predict that 120 million (93-150) deaths will be averted by vaccination, of which 58 million (39-76) are due to measles vaccination and 38 million (25-52) are due to hepatitis B vaccination. We estimate that increases in vaccine coverage and introductions of additional vaccines will result in a 72% (59-81) reduction in lifetime mortality in the 2019 birth cohort. INTERPRETATION: Increases in vaccine coverage and the introduction of new vaccines into LMICs have had a major impact in reducing mortality. These public health gains are predicted to increase in coming decades if progress in increasing coverage is sustained. FUNDING: Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Our World: The 2030 Agenda for Sustainable Development
(2018) · A New Era in Global Health · doi:10.1891/9780826190123.ap02 · Cited by 19,351
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692 · cited 1×
“…relevant for hepatitis B and HPV, for which cancer screening and treatment services can make a substantial difference to disease-related mortality, 22 and for measles, for which decreasing background mortality among children younger than 5 years can significantly reduce case-fatality ratios.”
Vaccination greatly reduces disease, disability, death and inequity worldwide
Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., et al. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.040089 · Cited by 1,234
Measuring trust in vaccination: A systematic review
Larson, H. J., Clarke, R. M., Jarrett, C., Eckersberger, E., Levine, Z., Schulz, W. S., & Paterson, P. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1459252 · Cited by 782
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743
Roush, S. W. (2007) · JAMA · doi:10.1001/jama.298.18.2155 · Cited by 633
(2013) · Vaccine · doi:10.1016/j.vaccine.2013.02.015 · Cited by 551
Expanded Programme on Immunization
(2001) · Immunization · doi:10.1002/9780470693841.ch8 · Cited by 392
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011–20
Ozawa, S., Clark, S., Portnoy, A., Grewal, S., Brenzel, L., & Walker, D. G. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1086 · Cited by 371
Ozawa, S., Mirelman, A., Stack, M. L., Walker, D. G., & Levine, O. S. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.103 · Cited by 254
Cited by
Infectious disease in an era of global change
Baker, R. E., Mahmud, A. S., Miller, I. F., Rajeev, M., Rasambainarivo, F., Rice, B. L., Takahashi, S., Tatem, A. J., Wagner, C. E., Wang, L.-F., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00639-z · Cited by 2,059
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Watson, O. J., Barnsley, G., Toor, J., Hogan, A. B., Winskill, P., & Ghani, A. C. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00320-6 · Cited by 1,769
Abbas, K., Procter, S. R., van Zandvoort, K., Clark, A., Funk, S., Mengistu, T., Hogan, D., Dansereau, E., Jit, M., Flasche, S., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30308-9 · Cited by 362
Self-citationGlobal reporting of progress towards elimination of hepatitis B and hepatitis C
Cui, F., Blach, S., Manzengo Mingiedi, C., Gonzalez, M. A., Sabry Alaama, A., Mozalevskis, A., Séguy, N., Rewari, B. B., Chan, P.-L., Le, L.-V., et al. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00386-7 · Cited by 327
Self-citationGalles, N. C., Liu, P. Y., Updike, R. L., Fullman, N., Nguyen, J., Rolfe, S., Sbarra, A. N., Schipp, M. F., Marks, A., Abady, G. G., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00984-3 · Cited by 215
Self-citation
Metadata
- Authors
- Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., Brisson, M., Carter, E. D., Clark, A., de Villiers, M. J., Eilertson, K., Ferrari, M. J., Gamkrelidze, I., Gaythorpe, K. A. M., Grassly, N. C., Hallett, T. B., Hinsley, W., Jackson, M. L., Jean, K., Karachaliou, A., Klepac, P., Lessler, J., Li, X., Moore, S. M., Nayagam, S., Nguyen, D. M., Razavi, H., Razavi-Shearer, D., Resch, S., Sanderson, C., Sweet, S., Sy, S., Tam, Y., Tanvir, H., Tran, Q. M., Trotter, C. L., Truelove, S., van Zandvoort, K., Verguet, S., Walker, N., Winter, A., Woodruff, K., Ferguson, N. M., & Garske, T.
- Affiliations
- Imperial College London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- National University of Singapore (SG)
- Public Health England (GB)
- Gavi (CH)
- Université Laval (CA)
- Johns Hopkins University (US)
- Colorado State University (US)
- Pennsylvania State University (US)
- Center for Disease Analysis (US)
- Kaiser Permanente (US)
- Conservatoire National des Arts et Métiers (FR)
- University of Cambridge (GB)
- University of Notre Dame (US)
- Oxford University Clinical Research Unit (VN)
- Harvard University (US)
- Corresponding author
- Ferguson, Neil M
- ORCID
- Li, Xiang
- Mukandavire, Christinah
- Cucunubá, Zulma M
- Abbas, Kaja
- Clapham, Hannah E
- Jit, Mark
- Johnson, Hope L
- Papadopoulos, Timos
- Vynnycky, Emilia
- Brisson, Marc
- Carter, Emily D
- Clark, Andrew
- Eilertson, Kirsten
- Ferrari, Matthew J
- Gamkrelidze, Ivane
- Gaythorpe, Katy A M
- Grassly, Nicholas C
- Hallett, Timothy B
- Hinsley, Wes
- Jackson, Michael L
- Jean, Kévin
- Klepac, Petra
- Lessler, Justin
- Li, Xi
- Moore, Sean M
- Nayagam, Shevanthi
- Nguyen, Duy Manh
- Razavi, Homie
- Resch, Stephen
- Sanderson, Colin
- Sy, Stephen
- Tam, Yvonne
- Tanvir, Hira
- Tran, Quan Minh
- Trotter, Caroline L
- Truelove, Shaun
- Verguet, Stéphane
- Walker, Neff
- Winter, Amy
- Woodruff, Kim
- Ferguson, Neil M
- Garske, Tini
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 397
- Issue
- 10272
- Pages
- 398-408
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC7846814
- OpenAlex
- W3123481858
- Cited by
- 300
- References
- 24
- Citations by year
- 2026: 39 · 2025: 50 · 2024: 49 · 2023: 65 · 2022: 48 · 2021: 44
- FWCI
- 28.56
- Type
- journal article
- Language
- en
- Update notices
- erratum (2021-02-20)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- National University of Singapore (submittedVersion, cc-by)
- HAL (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Greater South Information System
- Funders
- GAVI Alliance
- Bill and Melinda Gates Foundation
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Keywords
- childhood immunization, vaccine impact, mortality averted, disability-adjusted life years, measles vaccination, hepatitis B vaccination, Haemophilus influenzae type b, human papillomavirus, Japanese encephalitis, Neisseria meningitidis serogroup A, Streptococcus pneumoniae, rotavirus, rubella, yellow fever, low- and middle-income countries
- MeSH terms
- Child, Preschool, Communicable Disease Control, Communicable Diseases, Cost-Benefit Analysis, Developing Countries, Female, Humans, Male, Models, Theoretical, Mortality, Vaccination, Global Health, Immunization Programs, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. https://app.cochat.ai/papers/10.1016/s0140-6736(20)32657-x
- The paper
- Li, X., Mukandavire, C., Cucunubá, Z. M., Echeverria Londono, S., Abbas, K., Clapham, H. E., Jit, M., Johnson, H. L., Papadopoulos, T., Vynnycky, E., Brisson, M., Carter, E. D., Clark, A., de Villiers, M. J., Eilertson, K., Ferrari, M. J., Gamkrelidze, I., Gaythorpe, K. A. M., Grassly, N. C., . . . Garske, T. (2021). Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. The Lancet. https://doi.org/10.1016/s0140-6736(20)32657-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.